P

PMV Pharmaceuticals, Inc.

53 employees

PMV Pharmaceuticals is a developer of p53-targeted small molecule drugs for the treatment of cancer.

Investor insights

Sectors invested in

Health Care2
Biotechnology2
Pharmaceutical1
Medical1

Funding rounds participated in

$9.4M sweet spot round size

Most of their 2 investments are in rounds between $5.3M and $13M

Basic info

Industry

biotechnology research

Sectors

Medical Device
Biotechnology
Health Care
Biopharma

Date founded

2013

Investments made

A

Apitope raised $13M on September 29, 2015

Investors: Wyvernfund.com, Arthurian Life Sciences, Vesalius Biocapital and PMV Pharmaceuticals, Inc.

F

FF Pharmaceuticals BV raised $5.3M on January 23, 2013

Investors: Vesalius Biocapital and PMV Pharmaceuticals, Inc.

Funding rounds raised

Total raised

$74M

from 17 investors over 17 rounds

P

PMV Pharmaceuticals, Inc. raised $70M on August 3, 2020

Investors: Nextech Invest, Avoro Capital Advisors (formerly venBio Select Advisor), OrbiMed Advisors, Viking Global Investors, RA Capital Management, L.P. and Wellington Management

P

PMV Pharmaceuticals, Inc. raised $62M on November 13, 2019

Investors: Nextech Invest, Osage University Partners (OUP), Viking Global Investors, InterWest Partners and OrbiMed Advisors

P

PMV Pharmaceuticals, Inc. raised $74M on February 22, 2017

Investors: OrbiMed Advisors, Osage University Partners (OUP) and InterWest Partners

P

PMV Pharmaceuticals, Inc. raised $30M on December 2, 2014

Investors: Osage University Partners (OUP), InterWest Partners and OrbiMed Advisors

FAQ